THE EFFECT OF MOTIVATIONAL INTERVIEWING ON MENOPAUSE MYTHS AND POSTTRAUMATIC GROWTH IN POSTMENOPAUSAL WOMEN:RANDOMIZED CONTROLLED STUDY

This randomized controlled study aims to evaluate the effect of motivational interviewing on menopause myths and posttraumatic growth in postmenopausal women. Participants will be randomly assigned to an intervention group receiving four weekly motivational interviewing sessions or a control group receiving usual care. Outcomes will be assessed before and after the intervention using validated scales.

Study Overview

• Status: Not yet recruiting
• Conditions: Menopause; Postmenopausal State
• Intervention / Treatment: Behavioral: Motivational interviewing

Detailed Description

Menopause is a biological transition that may affect women physically, psychologically, and socially. Misconceptions regarding menopause may negatively influence adaptation to this period, while positive coping may support posttraumatic growth.

Motivational interviewing is a client-centered counseling approach designed to strengthen intrinsic motivation and promote positive behavioral change. This randomized controlled trial aims to determine the effect of motivational interviewing on menopause myths and posttraumatic growth in postmenopausal women.

The study will be conducted in Family Health Centers in Gaziantep, Turkey, with 96 postmenopausal women randomly assigned to intervention and control groups. The intervention group will receive four weekly face-to-face motivational interviewing sessions lasting 30-45 minutes. The control group will receive usual care without intervention.

Data will be collected at baseline and after intervention using the Menopause Myths Scale and the Posttraumatic Growth Scale.

• Study Type: Interventional
• Enrollment (Estimated): 96
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Women who have had their last menstrual period between 12 and 36 months ago,
• are literate,
• can read and write in Turkish,
• do not have any problems that may hinder communication, and
• do not have any diagnosed psychiatric illness will be included in the study.

Exclusion Criteria:

• Those receiving HRT treatment,
• Those whose last menstrual period was 36 months or more ago,
• Women receiving oncology treatment.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: control group; No intervention
Experimental: intervention group; The researcher provided training on motivational interviewing techniques to be applied to the experimental group prior to the intervention. Women were informed about the research, and those wishing to participate were given a voluntary information form to read, and their verbal and written consent was obtained. Before starting the Motivational Interview sessions, the client was informed about the duration, number, and timing of the sessions. Each motivational interview session with the women in the experimental group is planned to last approximately 30-45 minutes. A total of four motivational interview sessions will be conducted with the women in the experimental group, once a week. All sessions will be conducted by inviting the women to their family physician's office. During the motivational interview sessions, counseling will be provided on topics related to the menopausal period, aiming to change negative beliefs about menopause myths and increase post-traumatic growth levels.	Behavioral: Motivational interviewing; The researcher provided training on motivational interviewing techniques to be applied to the experimental group prior to the intervention. Women will be informed about the research, and those wishing to participate will be given a voluntary information form to read, and their verbal and written consent will be obtained. The client will be informed about the duration, number, and timing of the interviews before the start of the MG sessions. Each motivational interview session with the women in the experimental group is planned to last approximately 30-45 minutes. A total of four MG sessions will be conducted with the women in the experimental group, once a week. All sessions will be conducted by inviting the women to their family physician's office. During the MG sessions, counseling will be provided on topics related to the menopausal period in order to change the women's negative beliefs about menopause myths and to increase their post-traumatic growth levels after menopause.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
MENOPAUSE MYTHS SCALE	Women's perceptions of menopause were measured using the Menopause Myths Scale.	At the beginning and at the end of the 4-week intervention period

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Post-Traumatic Growth Scale	The Post-Traumatic Growth Scale was used to assess the extent to which menopause creates trauma in women's lives.	At the beginning and at the end of the 4-week intervention period

Collaborators and Investigators

• Sponsor: Inonu University

Study record dates

Study Major Dates

• Study Start (Estimated): May 1, 2026
• Primary Completion (Estimated): October 1, 2026
• Study Completion (Estimated): October 1, 2026

Study Registration Dates

• First Submitted: April 24, 2026
• First Submitted That Met QC Criteria: May 12, 2026
• First Posted (Actual): May 19, 2026

Study Record Updates

• Last Update Posted (Actual): May 19, 2026
• Last Update Submitted That Met QC Criteria: May 12, 2026
• Last Verified: May 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Health Services; Health Care Facilities Workforce and Services; Behavioral Disciplines and Activities; Directive Counseling; Counseling; Mental Health Services; Motivational Interviewing
• Other Study ID Numbers: 860686

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No